CADD Solis pumpprice

Remodulin is a prostacyclin vasodilator indicated for the treatment of pulmonary arterial hypertension (PAH; WHO Group 1) to diminish symptoms associated with exercise. Studies establishing effectiveness included patients with NYHA Functional Class II-IV symptoms and etiologies of idiopathic or heritable PAH (58%), PAH associated with congenital systemic-to-pulmonary shunts (23%), or PAH associated with connective tissue diseases (19%).

CADD Solis PumpTraining

In patients with PAH requiring transition from epoprostenol, Remodulin is indicated to diminish the rate of clinical deterioration. Consider the risks and benefits of each drug prior to transition.

The CADD®-Solis VIP ambulatory infusion pump is reliable for the continuous IV delivery of Remodulin and other medicines.1

Huangshan LEGOAL Locomotive Parts Co.,Ltd is located in Anhui province. The company established in 2003 as Hengtai Piston Co.,Ltd, and changed name to Legoal in 2015. Legoal is a professional car engine cylinder head and piston manufacturer, with Vast manufacture experience. We have more than 100 employers, including many professional engineers. Our factory covers the area more than 20000 square. We own a full set of advanced casting / heat treatment / machining and testing equipment. The company has a complete set of ISO9001and ISO/TS16949 quality certification system. 　　Our cylinder heads and pistons have been exported to more than twenty countries such as North & South America, Europe, Middle East area and Southeast Asia. We offer OEM to Chinese car maker and aftermarket products to global customer. The annual turnover have reach to 60 million RMB per year, and still keep increasing rapidly. The company has developed over one hundred model of cylinder head and piston, which are supplied for Nissan, Toyota, Hyundai, Honda and more.we have innovate design, strict quality control, competitive price and great after-sale service to be a best choose for the market. 　　LEGOAL is committed to provide high-quality products and superior services for global market. Welcome all interested colleagues to visit our factory to have a face to face talk,Thank you!

CADD Solis pumpManual

Remodulin is a prostacyclin vasodilator indicated for the treatment of pulmonary arterial hypertension (PAH; WHO Group 1) to diminish symptoms associated with exercise. Studies establishing effectiveness included patients with NYHA Functional Class II-IV symptoms and etiologies of idiopathic or heritable PAH (58%), PAH associated with congenital systemic-to-pulmonary shunts (23%), or PAH associated with connective tissue diseases (19%).

cadd-solispumpcheat sheet

For PAH (WHO Group 1) to diminish symptoms associated with exercise and to diminish the rate of clinical deterioration in patients transitioning from Flolan® (epoprostenol sodium).

CADD Solis pumpmanufacturer

In patients with PAH requiring transition from epoprostenol, Remodulin is indicated to diminish the rate of clinical deterioration. Consider the risks and benefits of each drug prior to transition.

CADD-Solis VIP

The Remodulin SPmix Program delivers up to 7 days of premixed IV Remodulin and all necessary supplies to your patients’ homes each week.

Please note that the rules for writing DAW vary by state. Our DAW Requirements Guide can help you find your specific state or territory requirements.

You are using a browser that is not supported by this site. The site will not function properly. Please switch to the latest version of a supported browser such as Chrome, Safari, Edge, or Firefox to use this site.

References: 1. Smiths Medical. CADD-Solis VIP™ Comparison Sheet. 2022. 2. Smiths Medical. CADD-Solis VIP™ Ambulatory Infusion System Brochure English. 2022. 3. Remodulin [package insert]. Research Triangle Park, NC: United Therapeutics Corporation; 2023.

All other brands are trademarks of their respective owners. The makers of these brands are not affiliated with and do not endorse United Therapeutics or its products.

To ensure patients receive your choice of Remodulin® (treprostinil), make sure to indicate “Dispense as Written, Brand Medically Necessary, and No Substitution” in the Prescriber Signature section of the Referral Form.